Raymond F. Vennare's most recent trade in Predictive Oncology Inc was a trade of 58,708 Common Stock done . Disclosure was reported to the exchange on Jan. 3, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Predictive Oncology Inc | Raymond F. Vennare | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 58,708 | 142,438 (3%) | 1% | 0 | Common Stock | |
Predictive Oncology Inc | Raymond F. Vennare | Director | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 02 Dec 2022 | 4,600 | 83,330 (2%) | 0% | 0.5 | 2,375 | Common Stock |
Predictive Oncology Inc | Raymond F. Vennare | Director | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 02 Dec 2022 | 400 | 83,730 (2%) | 0% | 0.5 | 207 | Common Stock |
Predictive Oncology Inc | Raymond F. Vennare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 16,667 | 78,730 (1%) | 0% | 0 | Common Stock | |
Predictive Oncology Inc | Raymond F. Vennare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 31,700 | 62,063 (1%) | 0% | 0 | Common Stock | |
Predictive Oncology Inc | Raymond F. Vennare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 6,142 | 30,363 (0%) | 0% | 0 | Common Stock | |
Predictive Oncology Inc | Raymond F. Vennare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 14,709 | 24,221 (0%) | 0% | 0 | Common Stock | |
Predictive Oncology Inc | Raymond F. Vennare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 4,512 | 9,512 (0%) | 0% | 0 | Common Stock | |
Predictive Oncology Inc | Raymond F. Vennare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2021 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock |